Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...

Please provide your email address to receive an email when new articles are posted on . Mitral annulus calcification may be an independent risk factor for all-cause mortality and was more common among ...

Please provide your email address to receive an email when new articles are posted on . The presence of mitral annular calcium was not associated with worse outcomes in patients who had transcatheter ...

ROCHESTER, Minn. — A retrospective review of more than 24,000 patients who underwent an EKG at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic ...

Patients with mitral annulus calcification are at more than double the risk for mitral valve dysfunction, a study published June 1 in Mayo Clinic Proceedings found. Researchers retrospectively ...

PARIS, France—Results from the Mitral Annular Calcification (MAC) Global Registry suggest that if patients can survive the complex initial procedure and its aftermath, they have a good chance of ...

PARIS--(BUSINESS WIRE)--HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe ...

A Kansas man became the first person in the world to receive a new treatment that's giving him new-found hope and extending his life. We caught up with George Esslinger during his one month follow up ...

CHICAGO, IL—There are at least 26 novel devices vying to prove their mettle in the transcatheter mitral valve repair space: several targeting leaflet coaptation, some focused on the mitral annulus, ...

INTRODUCTION Atherosclerosis is a systemic pathological process involving the whole arterial bed. Valvular calcifications are associated with cardiovascular risk factors. Significant carotid stenosis ...

Edwards Lifesciences, the Irvine, California-based medical device company is betting big on the transcatheter mitral valve therapies. On Monday, the structural heart company that dominates the ...